Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Midwest Bioprocessing Center
AddedFeb 17, 2024
UpdatedJun 18, 2026
Midwest Bioprocessing Center

Midwest Bioprocessing Center

Seed

Midwest Bioprocessing Center: Specializing in biotech R&D, organic chemical & pharmaceutical manufacturing.

HQ
Peoria, IL, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Midwest Bioprocessing Center specializes in biotechnology research and development, focusing on organic chemical and pharmaceutical manufacturing. The company offers a range of products and services, including rare sugars, biochemicals, biocatalysts, natural cosmetic ingredients, and custom bioprocess solutions. Their mission is to bring innovative bioprocess technologies and products to market, enhancing human health and nutrition through proprietary molecular biology, biocatalysis, and fermentation technologies.

The company has achieved significant milestones by partnering with zuCarb to advance research in rare sugars and biochemicals. Midwest Bioprocessing Center's growing catalog of products reflects its commitment to innovation and industry impact. Their work in developing new industrial compounds underscores their role as a key player in the biotech sector.

Midwest Bioprocessing Center - Similar Companies

BiotecEra logo

BiotecEra

biotecera.com

Capra Biosciences logo

Capra Biosciences

Microvi Biotech logo

Microvi Biotech

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

Biocee logo

Biocee

Biomedican logo

Biomedican

biomedican.com

OmegaChea logo

OmegaChea

Zymochem logo

Zymochem

zymochem.com

Zuchem logo

Zuchem

zuchem.com

AmideBio logo

AmideBio

amidebio.com

Genomatica logo

Genomatica

genomatica.com

Biomade logo

Biomade

Rbio logo

Rbio

rbio.online

Manus Bio logo

Manus Bio

Bluestem Biosciences logo

Bluestem Biosciences

Midwest Bioprocessing Center - Quick Facts

Who are Midwest Bioprocessing Center's competitors?

Companies similar to Midwest Bioprocessing Center include BiotecEra, Capra Biosciences, Microvi Biotech and Glycos Biotechnologies.

When was Midwest Bioprocessing Center founded?

Midwest Bioprocessing Center was founded in 2003.

Where is Midwest Bioprocessing Center's headquarters located?

Midwest Bioprocessing Center's headquarters is located in Peoria, IL, US.

When was Midwest Bioprocessing Center's last funding round?

Midwest Bioprocessing Center's most recent funding round was for $1.8M (USD) in December 2023.

How much has Midwest Bioprocessing Center raised to-date?

As of Dec 19, 2023, Midwest Bioprocessing Center has raised a total of $4.1M (USD).

How many employees does Midwest Bioprocessing Center have?

Midwest Bioprocessing Center has 9 employees as of Feb 4, 2024.

Midwest Bioprocessing Center - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Biocatalysts
  • Biochemicals
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified